Medoclav

Amoxicillin/clavulanic acid, the active ingredient in Medoclav, is a penicillin beta‑lactamase inhibitor presented as an oral tablet for bacterial infection treatment in adults and children. It is used to manage a range of community‑acquired infections.

GNH USA supplies Medoclav as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Medoclav, a combination antibacterial, is indicated for several common bacterial infections affecting the respiratory, ear, urinary and skin systems.

- Acute sinusitis: reduces bacterial load and alleviates symptoms in patients with sinus infection. - Community‑acquired pneumonia: treats lower respiratory tract infection caused by susceptible organisms. - Acute otitis media: clears middle‑ear infection and improves hearing discomfort. - Urinary tract infections: eradicates susceptible uropathogens and resolves urinary symptoms. - Skin and soft‑tissue infections: combats bacterial skin infections and promotes healing.

Adverse reactions to Medoclav vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, often self‑limiting. - Abdominal pain: cramping or discomfort in the abdomen. - Rash: mild skin redness or itching. - Headache: transient head pain. - Taste disturbance: altered taste perception.

Serious or Rare Side Effects: - Anaphylaxis: severe, potentially life‑threatening allergic reaction. - Clostridioides difficile‑associated colitis: severe diarrhea due to bacterial overgrowth. - Hepatic enzyme elevation: increased liver transaminases indicating liver stress. - Stevens‑Johnson syndrome: rare severe skin and mucous membrane reaction. - Neutropenia: marked reduction in white blood cells.

Before prescribing Medoclav, clinicians should consider the following precautions.

- Allergy assessment: confirm no known hypersensitivity to penicillins or clavulanic acid. - Renal function: adjust dose in patients with impaired kidney function. - Hepatic impairment: monitor liver enzymes in patients with liver disease. - Concomitant antibiotics: avoid use with other β‑lactam antibiotics to reduce resistance risk. - Pregnancy and lactation: evaluate risk‑benefit as safety data are limited. - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture.

Medoclav may interact with other medicines; notable interactions are grouped by clinical significance.

Major Interactions (Avoid): - Probenecid: can increase amoxicillin plasma concentrations, raising toxicity risk. - Oral contraceptives: may reduce hormonal efficacy, increasing pregnancy risk. - Allopurinol: heightened risk of severe skin rash. - Methotrexate: may amplify methotrexate toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: amoxicillin may potentiate anticoagulant effect, requiring INR monitoring. - Aminoglycosides: possible antagonistic effect reducing antibacterial activity.